Eli Lilly (LLY)

• Market cap: $911B
• 1 day: 2.95%
• 5 days: 9.67%
• 1 month: 24.21%
• 3 months: 59.17%
• 6 months: 34.7%
• Year to date: 30.81%
• 1 year: 24.29%
• 5 years: 621.68%
• 10 years: 1,174.46%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000